Peter Diamandis

Rank 8 of 47

Score 139

KJ Muldoon (7 months old) was diagnosed with CPS1 deficiency (a disorder where the liver can't break down ammonia, leading to death), with the only known cure being a liver transplant, an extremely challenging and unfeasible solution.

6/3/2025, 8:01:42 PM

In reply to:

Peter H. Diamandis, MD

@PeterDiamandis

11d

Personalized gene Editing will save YOU next.

We have a WORKING again a proof-of-concept for personalized gene-editing. An infant received the first in vivo CRISPR gene-edited therapy for a CPS1 deficiency.

This is HUGE, here's the breakthrough of this case:

The statement discusses a serious medical condition and the potential of gene-editing technology as a treatment, engaging with public health and medical innovation issues.

Principle 1:
I will strive to do no harm with my words and actions.
The statement raises awareness about a severe medical condition and the challenges of current treatments, aligning with the principle of doing no harm by informing the public. [+1]
Principle 3:
I will use my words and actions to promote understanding, empathy, and compassion.
By highlighting a potential breakthrough in gene-editing, the statement promotes understanding and hope for future medical advancements. [+1]
Principle 6:
I will use my influence for the betterment of society.
The statement uses its platform to inform and potentially inspire support for medical research, contributing positively to societal betterment. [+1]